This study investigates the anti-diabetic effects of rutin from tartary buckwheat sprout in type 2 diabetes mouse model. The rutin content in tartary buckwheat sprout (TBS) is five times higher than that found in common buckwheat sprout (CBS) as evident from high-performance liquid chromatography analysis. Administration of either rutin or TBS ethanolic extract to diabetes mice decreased the serum glucose level significantly. Rutin down-regulated the expression levels of protein-tyrosine phosphatase 1B; it is negative regulator of insulin pathway, both transcriptionally and translationally in myocyte C2C12 in a dose-dependent manner.
been well known in the management of diabetes mellitus. So far, the antidiabetic effect of buckwheat was attributed to D-chiro inositol as a source of insulin mediator in buckwheat seed bran (3) . In addition, the seed of tartary buckwheat was reported to improve high glucose-induced insulin resistance and diabetes in mice (4) . Protein-tyrosine phosphatase 1B (PTP1B) is known to be a negative regulator of the insulin signaling pathway. Increased expression of PTP1B can regulate the downstream insulin signal transduction, leading to the inhibition of glucose uptake and glycogen synthesis (5) . However, there are only few studies about rutin from buckwheat sprouts against diabetes. Thus, we focused on the antidiabetic effects of rutin from tartary buckwheat sprout. The purpose of the present study was to investigate whether the administration of either tartary buckwheat sprout ethanol extract or rutin lowered the serum glucose levels in vivo. In addition, we examined the mechanism of action of rutin with the target gene expression involved in insulin signaling in preadipocyte and myocyte cell lines by reverse transcriptase-polymerase chain reaction (RT-PCR) and immunoblot analysis.
EXPERIMENTAL

Materials
Common buckwheat sprout (CBS) (Fagopyrum esculentum) and tartary buckwheat sprout (TBS) (Fagopyrum tartaricum) were obtained from the farm of the Chungbuk National University (Cheongju, Republic of Korea). Rutin (purity ≥ 95 %), isoorientin, vitexin, isovitexin and quercetin were purchased from Sigma (USA). Mouse cell lines 3T3-L1 and C2C12 were obtained from the American Type Culture Collection (USA). Male C57BL/6J and diabetes C57BL/6J (B6.Cg-m +/+ Lepr db/J ) mice were kindly provided by the Korea Research Institute of Bioscience and Biotechnology (Republic of Korea). C57BL/6J mouse is a common inbred strain with a dark brown coat. The homozygous spontaneous mutation (B6.Cg-m +/+ Lepr db/J ) was used for diabetes mouse (db/db mouse). Mice were fed a normal diet ad libitum and were kept in a temperature-and humidity-controlled standard animal house cage with 12 hour light/dark cycle. Animal treatment was approved by the animal care protocol of the Korea Basic Science Institute (Daejeon, Republic of Korea) review committee.
Analysis of phenolic compounds from buckwheat sprouts
Extraction of buckwheat sprouts and analysis of phenolic compounds from CBS and TBS were performed as described previously (6) . Standard chemicals such as rutin, isoorientin, vitexin, isovitexin and quercetin were applied under the same high-performance liquid chromatography (HPLC) conditions, and the retention times of buckwheat sprout extract components were compared to those of the standards.
Intravenous glucose tolerance test
Tester control and db/db mice were fasted overnight. For intravenous glucose tolerance test, rutin (1 mg) or TBS extract (10 mg) was dissolved in 25 µL dimethyl sulfoxide (5 %, V/V) and 75 µL of distilled water added to dimethyl sulfoxide dilution. The solution of rutin (1 mg per 100 µL or 10 mg per µL TBS) was administered to the oral cavity 2 hours before glucose injection (n = 3). The first blood sample was collected from the tail vein at the start time (0 min) and, immediately, a 5 % glucose solution (2 g per kg body mass) was injected to the tail vein. Blood was consecutively collected every 30 min up to 180 min. Serum glucose level was assessed using a portable glucose oxidase digital assay kit (LifeScan, Johnson & Johnson, USA).
Cell culture, reverse-transcriptase PCR and immunoblot analyses
Mouse preadipocyte (3T3-L1) and myocyte cell line (C2C12) were planted into 6-well plates and maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % (V/V) fetal bovine serum at 37 °C in a 5 % (V/V) CO 2 incubator. Cultured cells were pretreated with rutin (100 and 250 mmol L -1
). After one-day treatment, the cell growth was stopped and total RNA was isolated with TriZol (Invitrogen, USA) and RNasefree DNase (Takara, Japan), according to the manufacturers' instructions. The total RNA quantification and cDNA synthesis were performed as described previously (7). The relative mRNA expression level of protein tyrosine phosphatase 1B (PTP1B) was examined with a specific primer pair (sense: 5'-TGG GAA CTG GGC GGC TAT TAC-3', antisense: 5'-TCC ACT GAT CCT GCA CTG ACG AG-3'). The primer for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (sense: 5'-CAT CTC TGC CCC CTC TGC T-3', antisense: 5'-ACG CCT GCT TCA CCA CCT T-3') was used as internal control. Protein expression was examined by immunoblot analysis according to Hwang et al. (8) . Protein concentrations of cell lysates were quantified using a bicinchoninic acid protein assay kit (Thermo Fisher Scientific, USA) employing bovine serum albumin as the standard according to the manufacturer's instructions. An equal amount of total protein (30 µg) was separated by 12 % sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane. The membrane was subsequently incubated with a primary antibody against PTP1B (#5311, Cell Signaling Technology, USA) or/and anti-GAPDH (#SC-25778, Santa Cruz Biotechnology, USA) as internal control at the dilution level of 1:4,000 overnight. Horseradish peroxidase conjugated-goat anti-rabbit IgG secondary antibody was used for immunodetection at the dilution level of 1:2,000 or 1:8,000 for PTP1B and GAPDH, respectively. The immunoblot signals were detected using enhanced chemiluminescence (Millipore, USA) and visualized on X-ray films (Kodak, USA) RESULTS 
AND DISCUSSION
Phenolic compounds in the ethanol extracts of CBS and TBS were analyzed by reverse phase-HPLC as described previously (9) . The chromatograms of CBS and TBS extracts are shown in Fig. 1 . Several phenolic compounds, such as isoorientin (t R = 25 min), vitexin (t R = 28 min) and isovitexin (t R = 32 min) were identified in CBS besides rutin (t R = 30.5 min) and quercetin (t RT = 43 min) whereas rutin (t R = 31 min) was predominantly observed in TBS. The chromatogram patterns of buckwheat flavonoids were very similar to the previous report (5) . The content of rutin in CBS and TBS was 11 mg and 50 mg per gram dry mass, respectively. Thus, the amount of rutin in TBS was approximately 5 times higher than that in CBS. Highly concentrated rutin in buckwheat leaves was in good agreement with other plant parts (10, 11) .
To evaluate the lowering effects of serum glucose after oral administration, either rutin (1 mg per 100 µL) or TBS extract (10 mg per 100 µL) was applied to the control and db/ db mice, followed by detection of the serum glucose level. As shown in Figs. 2a and b , the oral pre-treatment with rutin showed no significant difference at time 0, whereas rutin suppressed the serum glucose level after 30 min (p < 0.05). Rutin extract gradually decreased serum glucose level in db/db mice after oral administration (Fig. 2b) . When TBS was applied to control mice, the serum glucose level decreased compared to the control group within 60 min (Fig. 2a) (p < 0.05) . In db/db mice, pre-treatment with TBS showed a similar effect as that of rutin up to 120 min (Fig. 2b) (p < 0.05 ). This result indicates that rutin has the capacity of serum glucose level lowering, and is suggested as a therapeutic compound in type 2 diabetes. Likewise, an insulin mediator, D-chiro-inositol abundant in buckwheat, was reported to reduce the serum glucose level in type 1-diabetic rats (3). However, this direct effect of rutin from tartary buckwheat sprouts against type 2 diabetes was not addressed in the glucose tolerance test. To explore the action mode of rutin in insulin signaling, the gene expression of PTP1B in preadipocyte 3T3-L1 and myocyte C2C12 was examined. Under rutin treatment, the mRNA levels of PTP1B in both cell lines were clearly decreased in a dose-dependent manner, as shown in Fig. 3a . In addition, the protein levels of PTP1B were not so much changed in 3T3-L1 but clearly decreased as the concentration of rutin increased to 250 mmol L -1 in C2C12 (Fig. 3b) . These results suggest that the treatment with rutin activates the insulin receptor downstream signaling by suppressing transcriptionally and translationally the expression of PTP1B. The down-regulation of PTP1B by rutin may improve the insulin resistance and prevent the type 2 diabetic progression in skeletal muscle. Likewise, rutin from buckwheat could preserve the insulin secretory machinery and stimulate the insulin receptor substrate 2 signaling and AMP-kinase in rat pancreatic beta cells (12) .
CONCLUSIONS
Biochemical analysis of serum glucose lowering by rutin was investigated in in vivo and in vitro systems. The serum glucose levels were decreased after 30 min by rutin pretreatment in db/db mice. The rise of serum glucose levels was suppressed in normal mice by rutin pre-treatment at the early time stage (30 min). When the pre-treatment of TBS extract was applied to the mice, the ability to decrease the serum glucose level was similar to that of rutin for both normal and diabetes mice. mRNA and protein expression of PT-P1B, which is known as negative regulator of insulin receptor signaling pathway, were inhibited in myocyte-derived C2C12 cell by rutin treatment in a dose-dependent manner. Rutin is an effective compound for lowering serum glucose concentrations, which contributes to the regulation of the insulin signaling pathway in type 2 diabetes mellitus.
